Ratios of percentage injected 131I dose/g between target (tumor, marrow, spleen) and nontarget organs after 131I-30F11 (antimurine CD45) in a EL-4 (murine T-NHL) model (24 hours)
| Nontarget organ . | Tumor/organ . | P . | Bone marrow/organ . | P . | Spleen/organ . | P . |
|---|---|---|---|---|---|---|
| Blood | 5.9 | .00050 | 9.6 | .00843 | 19.0 | .00005 |
| Lung | 5.3 | .00095 | 10.6 | .01180 | 16.1 | .00004 |
| Liver | 5.4 | .00071 | 8.8 | .01092 | 16.9 | .00005 |
| Stomach | 3.6 | .00165 | 4.9 | .02690 | 11.3 | .00006 |
| Kidney | 8.7 | .00065 | 15.6 | .00861 | 27.3 | .00004 |
| Small intestine | 5.6 | .00102 | 10.9 | .01279 | 17.2 | .00004 |
| Large intestine | 11.8 | .00070 | 21.8 | .00875 | 36.2 | .00004 |
| Nontarget organ . | Tumor/organ . | P . | Bone marrow/organ . | P . | Spleen/organ . | P . |
|---|---|---|---|---|---|---|
| Blood | 5.9 | .00050 | 9.6 | .00843 | 19.0 | .00005 |
| Lung | 5.3 | .00095 | 10.6 | .01180 | 16.1 | .00004 |
| Liver | 5.4 | .00071 | 8.8 | .01092 | 16.9 | .00005 |
| Stomach | 3.6 | .00165 | 4.9 | .02690 | 11.3 | .00006 |
| Kidney | 8.7 | .00065 | 15.6 | .00861 | 27.3 | .00004 |
| Small intestine | 5.6 | .00102 | 10.9 | .01279 | 17.2 | .00004 |
| Large intestine | 11.8 | .00070 | 21.8 | .00875 | 36.2 | .00004 |